» Articles » PMID: 38126221

A Systematic Review of the Efficacy, Safety and Satisfaction of Regenerative Medicine Treatments, Including Platelet-rich Plasma, Stromal Vascular Fraction and Stem Cell-conditioned Medium for Hypertrophic Scars and Keloids

Overview
Journal Int Wound J
Date 2023 Dec 21
PMID 38126221
Authors
Affiliations
Soon will be listed here.
Abstract

The primary objective of this study is to examine the efficiency of various regenerative medicine approaches, such as platelet-rich plasma, cell therapy, stromal vascular fraction, exosomes and stem cell-conditioned medium, in the process of healing hypertrophic and keloid scars. Major databases including PubMed, Scopus and Web of Science were systematically searched, and based on the content of the articles and the inclusion and exclusion criteria, eight articles were selected. Out of these eight articles, there were two non-randomized clinical trial studies (25%), one randomized, single-blinded comparative study (12.5%), one retrospective clinical observational study (12.5%) and four randomized clinical trial studies (50%). We employed EndNote X8 and Google Sheets to conduct article reviews and extract relevant data. Following the review phase, the studies underwent analysis and categorization. In all eight reviewed studies, the effectiveness of regenerative medicine in treating hypertrophic scars and keloids has been proven. Out of these studies, five (62.5%) focused on the effectiveness of platelet-rich plasma, two study (25%) examined the effectiveness of stromal vascular fraction and one study (12.5%) explored the efficacy of stem cell-conditioned medium. In two studies (25%), the treatment methods were added to standard treatment, while in six studies (75%), regenerative medicine was used as the sole treatment method and compared with standard treatment. The use of these treatment methods did not result in any serious side effects for the patients. Regenerative medicine is an effective method with minimal side effects for the treatment of hypertrophic scars and keloids. It can be used as a monotherapy or in combination with other treatment methods. However, further studies are needed to thoroughly evaluate the effectiveness of all sub-branches of this method.

Citing Articles

Functional regeneration strategies of hair follicles: advances and challenges.

Chu X, Zhou Z, Qian X, Shen H, Cheng H, Zhang J Stem Cell Res Ther. 2025; 16(1):77.

PMID: 39985119 PMC: 11846195. DOI: 10.1186/s13287-025-04210-y.


Evaluating the effectiveness and safety of pulsed dye laser alone, the combination of pulsed dye laser and botulinum toxin type A, and the combination of pulsed dye laser and triamcinolone injection in the treatment of hypertrophic and keloid scars:....

Atefi N, Jafari M, Roohaninasab M, Dehghani A, Jafarzadeh A, Peighambari S Lasers Med Sci. 2025; 40(1):92.

PMID: 39953344 DOI: 10.1007/s10103-025-04338-6.


The role of platelet-rich plasma in biomedicine: A comprehensive overview.

Zhang Z, Liu P, Xue X, Zhang Z, Wang L, Jiang Y iScience. 2025; 28(2):111705.

PMID: 39898035 PMC: 11787504. DOI: 10.1016/j.isci.2024.111705.


A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo.

Jafarzadeh A, Mohammad A, Goodarzi A J Cosmet Dermatol. 2024; 24(2):e16660.

PMID: 39509558 PMC: 11847760. DOI: 10.1111/jocd.16660.


A systematic review of procedural treatments for burn scars in children: Evaluating efficacy, safety, standard protocols, average sessions and tolerability based on clinical studies.

Roohaninasab M, Najar Nobari N, Ghassemi M, Behrangi E, Jafarzadeh A, Sadeghzadeh-Bazargan A Int Wound J. 2024; 21(10):e70091.

PMID: 39379072 PMC: 11461021. DOI: 10.1111/iwj.70091.


References
1.
McBride J, Rodriguez-Menocal L, Badiavas E . Extracellular Vesicles as Biomarkers and Therapeutics in Dermatology: A Focus on Exosomes. J Invest Dermatol. 2017; 137(8):1622-1629. DOI: 10.1016/j.jid.2017.04.021. View

2.
Ren Y, Deng C, Wan W, Zheng J, Mao G, Yang S . Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation. Mol Med Rep. 2014; 11(4):2471-6. PMC: 4337479. DOI: 10.3892/mmr.2014.3115. View

3.
Hu C, Tseng Y, Lee C, Chiou C, Chuang S, Yang J . Combination of mesenchymal stem cell-conditioned medium and botulinum toxin type A for treating human hypertrophic scars. J Plast Reconstr Aesthet Surg. 2019; 73(3):516-527. DOI: 10.1016/j.bjps.2019.07.010. View

4.
Yildiz E . Triple treatment in ear keloids: Comparison of post-excisional intralesional steroid and platelet-rich plasma treatment. Am J Otolaryngol. 2021; 42(3):102935. DOI: 10.1016/j.amjoto.2021.102935. View

5.
Dieckmann C, Renner R, Milkova L, Simon J . Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp Dermatol. 2010; 19(8):697-706. DOI: 10.1111/j.1600-0625.2010.01087.x. View